WBA Sep 2024 8.500 call
| Previous close | 0.2700 |
| Open | 0.2800 |
| Bid | 0.0500 |
| Ask | 0.3400 |
| Strike | 8.50 |
| Expiry date | 2024-09-06 |
| Day's range | 0.1500 - 0.5600 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.73k |
ReutersBaltimore settles with Teva, Walgreens ahead of scheduled opioid trial
Baltimore said on Tuesday that it has settled with Walgreens over claims that the pharmacy operator fueled opioid addiction in the Maryland city, the latest in a series of settlements totaling $402.5 million ahead of a trial scheduled to begin next week. The announcement came a day after the city reached an $80 million settlement over opioids with drugmaker Teva Pharmaceutical. Baltimore did not disclose the terms of its settlement with Walgreens, but the cumulative settlement amount implies that it was also $80 million.
- Business Wire
Walgreens Boots Alliance Schedules Fourth Quarter and 2024 Fiscal Year-End Earnings Announcement for October 15
DEERFIELD, Ill., September 09, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fourth quarter and 2024 fiscal year-end results at 7 a.m. ET on Tuesday, October 15, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET.
ZacksWhy the Market Dipped But Walgreens Boots Alliance (WBA) Gained Today
In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $8.77, denoting a +0.34% change from the preceding trading day.
